310
Participants
Start Date
November 2, 2017
Primary Completion Date
October 17, 2018
Study Completion Date
October 17, 2018
Placebo
Placebo was administered once daily
200mg SPN-812
200mg SPN-812 was administered once daily and compared to placebo
400mg SPN-812
400mg SPN-812 was administered once daily and compared to placebo
Icahn School of Medicine at Mount Sinai, New York
Finger Lakes Clinical Research, Rochester
Clinical Neuroscience Solutions, Inc, Jacksonville
Indago Research & Health Center, Inc., Hialeah
Miami Clinical Research, Miami
Harmonex Neuroscience Research, Dothan
Clinical Neuroscience Solutions, Inc., Memphis
Texas Physicians Medical Research Group, Arlington
Houston Clinical Trials, Houston
Family Psychiatry of the Woodlands, The Woodlands
Advanced Clinical Research, Meridian
Neuropsychiatric Research Center of Orange County, Orange
Supernus Pharmaceuticals, Inc.
INDUSTRY